跳至主要内容
临床试验/CTRI/2024/05/067550
CTRI/2024/05/067550尚未招募2 期

A comparative study to evaluate efficacy and safety of daily versus alternate day rosuvastatin therapy in patients with dyslipidemia - NI

George T Varghese0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients willing to give written informed consent.
  • 2. Patients aged more than 18 and less than or equal to 65 years.
  • 3. Treatment naive patients of dyslipidemia in low to moderate risk group as diagnosed by NCEP ATP III guidelines

排除标准

  • 1. Patients unwilling to give written informed consent.
  • 2. Patients with a documented history of acute coronary syndrome, cerebrovascular accident, on-going angina.
  • 3. Pregnant and lactating mothers.
  • 4. Patients on co-existing medication which aggravate statin myopathy.

研究者

发起方
George T Varghese

相似试验